Ra Pharmaceuticals CEO Douglas Treco's 2018 pay falls 36% to $2M
Ra Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Ra Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, three executives at Ra Pharmaceuticals received on average a compensation package of $1.4M, a 32% decrease compared to previous year.
Average pay of disclosed executives at Ra Pharmaceuticals
Douglas A. Treco, Chief Executive Officer, received $2M in total, which decreased by 36% compared to 2017. 34% of Treco's compensation, or $682K, was in option awards. Treco also received $330K in non-equity incentive plan, $500K in salary, $458K in stock awards, as well as $8.3K in other compensation.
Ramin Farzaneh-Far, Chief Medical Officer, received a compensation package of $1.2M, which decreased by 21% compared to previous year. 35% of the compensation package, or $400K, was in salary.
David C. Lubner, Chief Financial Officer, earned $1.1M in 2018, a 34% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2019.